---
layout: post
title:  "C52 aptamer"
date:   2024-05-06 00:00:00
author: Ke Chen, Yangyi Ren
categories: Aptamer
---
<!--p style="font-size: 24px"><strong>Keywords: </strong> <br/></p>
<font ><strong>small molecule, Synthetic, dyes, PubChem CID 25863</strong></font >
<br /-->

<html>
<head>
  <title>横向排列的点击按钮</title>
  <style>
    /* 按钮容器样式 */
    .button-container {
      display: flex;
      justify-content: left;
      align-items: center;
      height: 50px;
    }
    /* 按钮样式 */
    .button {
      display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: center;
      background-color: #ffffff;
      color: #520049;
      text-decoration: none;
      border: 1px solid #520049;
      border-radius: 5px;
    }
    /* 鼠标悬停样式 */
    .button:hover {
      background-color: #c9c5c5;
      cursor: pointer;
    }
  </style>
</head>
<!--body>
  <p style="font-size: 16px">Click the buttons to navigate to different sections:</p>
  <div class="button-container">
    <a class="button" style="color:#520049" href="#description">Description</a>
    <a class="button" style="color:#520049" href="#SELEX">SELEX</a>
    <a class="button" style="color:#520049" href="#structure">Structure</a>
    <a class="button" style="color:#520049" href="#ligand-recognition">Ligand recognition
    <a class="button" style="color:#520049" href="#references">References</a>
   </a>
  </div>
</body-->
</html>

<html lang="zh-cn">
<head>
<meta charset="utf-8"> 
<style>
    .header_box {
     display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: center;
      background-color: #efefef;
      color: #000000;
      text-decoration: none;
      border: 1px solid #c9c5c5;
      border-radius: 5px;
      width:225px;
	    height:50px;
  }
  .header_boxx1 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:115px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx2 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:140px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx3 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:85px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx4 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:120px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx5 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:215px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx6 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:135px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .blowheader_box{
    display: block;
      padding: 10px;
      font-size:18px;
      margin-right: 10px;
      text-align: center;
      background-color: #efefef;
      color: #000000;
      text-decoration: none;
      border: 1px solid #ffffff;
      border-radius: 5px;
      width:170px;
	    height:40px;
  }
  .box_style{
    background: #ffffff;
  }
  blockquote {
  margin: 0 0 0px;
  }
</style>
</head>
<br>
<br>


<p class="header_boxx1" id="timeline">Timeline</p>
<div class="timeline">
  <div class="entry">
  <div class="title">
    <h3><a href="https://pubmed.ncbi.nlm.nih.gov/8523524/" target="_blank" style="color:#520049">1996</a></h3>
  </div>
  <div class="body">
    <p>Aptamers were found to be functionally equivalent to the RBE when the assay system was saturated with Rev and better than the wild-type element when Rev was limiting<sup>[<a href="#ref1" style="color:#520049">1</a>]</sup></p>
  </div>
 </div>
            
 <div class="entry">
  <div class="title">
    <h3><a href="https://pubmed.ncbi.nlm.nih.gov/8755498/" target="_blank" style="color:#520049">1996</a></h3>
  </div>
  <div class="body">
    <p>Using the SELEX method, Wei Xu and colleagues obtained a series of anti-peptide aptamers that can recognize amino acid sequences<sup>[<a href="#ref2" style="color:#520049">2</a>]</sup></p>
  </div>
 </div>
            
 <div class="entry">
  <div class="title">
    <h3><a href="https://pubmed.ncbi.nlm.nih.gov/8946856/" target="_blank" style="color:#520049">1996</a></h3>
  </div>
  <div class="body">
    <p>HIV-1 17-mer rev peptide and RNA aptamer complex formation involves adaptive binding with the alpha-helical arginine-rich basic rev peptide targeting a widened RNA major groove centred about adjacent G.A and reversed A.A mismatches<sup>[<a href="#ref3" style="color:#520049">3</a>]</sup></p>
  </div>
 </div>
            
 <div class="entry">
  <div class="title">
    <h3><a href="https://pubmed.ncbi.nlm.nih.gov/9713975/" target="_blank" style="color:#520049">1998</a></h3>
  </div>
  <div class="body">
    <p>Specific inhibition of viral p24 production following co-transfection of the anti-HIV Rev-binding aptamer and HIV proviral DNAs was observed<sup>[<a href="#ref4" style="color:#520049">4</a>]</sup></p>
  </div>
 </div>
            
 <div class="entry">
  <div class="title">
    <h3><a href="https://pubmed.ncbi.nlm.nih.gov/15610009/" target="_blank" style="color:#520049">2004</a></h3>
  </div>
  <div class="body">
    <p>More than half of the residues have increased flexibility in the Rev-RNA aptamer complex that has a higher affinity. This further suggests that the retention of conformational flexibility may be important in high-affinity ARM-RNA recognition<sup>[<a href="#ref5" style="color:#520049">5</a>]</sup></p>
  </div>
 </div>
            
 <div class="entry">
  <div class="title">
    <h3><a href="https://pubmed.ncbi.nlm.nih.gov/30017564/" target="_blank" style="color:#520049">2018</a></h3>
  </div>
  <div class="body">
    <p>Altaira D. Dearborn et al. present the crystal structure of Rev93:scFv:RBA-14 Ternary Complex at 3.0 Å through X-ray<sup>[<a href="#ref6" style="color:#520049">6</a>]</sup></p>
  </div>
 </div>
</div>





<font ><p class="header_boxx2" id="description">Description</p></font>
<font >In 1996, Wei Xu and colleagues used the SELEX method to isolate the anti-peptide aptamers with high affinity for the HIV-1 Rev protein. Several of the selected RNAs could bind the free peptide more tightly than a natural RNA ligand, the Rev-binding element<sup>[<a href="#ref2" style="color:#520049">2</a>]</sup>.<br></font>
<br>
<br>


<p class="header_boxx3" id="SELEX">SELEX</p>
<p>In 1996, Wei Xu and colleagues used existing research to design the method required for the SELEX process. The RNA recognition domain of HIV-1 Rev is an ARM that spans residues 34-50. A 17-mer peptide (sRev) corresponding to this domain was used as a target for in vitro selection experiments. A RNA pool containing 71 random sequence positions was incubated with an affinity resin containing sRev<sup>[<a href="#ref2" style="color:#520049">2</a>]</sup>.<br>
Detailed information are accessible on <a href="{{ site.url }}{{ site.baseurl }}/SELEX" target="_blank" style="color:#520049"><b><i>SELEX</i></b></a> page.</p>
<br>
<br>


<p class="header_boxx4" id="Structure">Structure</p>
<font>C52 was the aptamer sequence mainly studied in the article, which had a high affinity with HIV-1 Rev protein. The 2D structure of the figures is based on the prediction results of the RNA fold website by ribodraw tool to draw<sup>[<a href="#ref2" style="color:#520049">2</a>]</sup>.<br></font>
<font><p>5'-GGGAGAUACCAGCUUAUUCAAUUGCUUGGUACCGAGCUCGGAUCCACGUAGUAACGGGCCGCCAGUGUCUGGAAUUCGGGUCGUUCUUGAGAUAGUAAGUGCAAUCU-3'</p></font>
<!--b>2D representation</b-->
        
<!--font><p>Szostak et al. obtained 17 different sequences through SELEX, and designed a 40nt sequence after comparing the information of 17 sequences. The aptamer of the 40nt is a sequence of analytic structures, and the following diagram shows its secondary structure.
Through SELEX, 17 different sequences were obtained, and after comparing 17 sequence information, a 40nt sequence was designed
 <sup>[<a href="#ref2" style="color:#520049">2</a>]</sup>.</p></font-->
<img src="/images/2D/C52_aptamer_2D.svg" alt="drawing" style="width:800px;display:block;margin:0 auto;border-radius:0;" class="img-responsive">
<div style="display: flex; justify-content: center;">   
</div>
 <br>
                     
<!--b>3D visualisation</b><br>               
<font >ATP aptamer complex was generated from PDB ID:  at 3.05 Å . Additional available structures that have been solved and detailed information are accessible on <i>Structures</i> page <sup>[<a href="#ref3" style="color:#520049" >3</a>]</sup>.</font>
  <table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;"><tr>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/3D/AMP-3D.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  <td style="text-align:center;padding-bottom: 0px;padding-right: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/3D/AMP-3D-bp.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  </tr>
  </table-->
  <br>

<font ><p class="header_boxx5" id="ligand-information">Ligand information</p></font>  
  

<p class="blowheader_box">SELEX ligand</p>
<font>REV is a viral anti-repression trans-activator protein, which appears to act post-transcriptionally to relieve negative repression of GAG and ENV production. It is a phosphoprotein whose state of phosphorylation is mediated by a specific serine kinase activity present in the nucleus. REV accumulates in the nucleoli.-----from Pfam</font>
<br>
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(0)">Name</th>
        <th onclick="sortTable(1)">Uniprot ID</th>
        <th onclick="sortTable(2)">Pfam</th>
        <th onclick="sortTable(3)">MW</th>
        <th onclick="sortTable(4)">Amino acids sequences</th>
        <th onclick="sortTable(5)">PDB</th>
        <th onclick="sortTable(6)">Gene ID</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td0">HIV-1 Rev protein</td>
        <td name="td1"><a href="https://www.uniprot.org/uniprotkb/P04616/entry#function" target="_blank" style="color:#520049"><b>P04616</b></a></td>
        <td name="td2"><a href="https://www.ebi.ac.uk/interpro/entry/pfam/PF00424/" target="_blank" style="color:#520049"><b>PF00424</b></a></td>
        <td name="td3">3.22 kDa</td>
        <td name="td4">GAMATRQARRNRRRRWRERQRAAAAR(residue 34-50)</td>
        <td name="td5"><a href="https://www.rcsb.org/structure/2M1A" target="_blank" style="color:#520049"><b>2M1A</b></a></td>
        <td name="td6"><a href="https://www.ncbi.nlm.nih.gov/protein/AAA44200.1" target="_blank" style="color:#520049"><b>AAA44200.1</b></a></td>
      </tr>
	  </tbody>
  </table>
<font>Some isolated sequences bind to the affinity of the protein.</font>
<br>
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(0)">Name</th>
        <th onclick="sortTable(1)">Sequence</th>
        <th onclick="sortTable(2)">Ligand</th>
        <th onclick="sortTable(3)">Affinity</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td0">C52</td>
        <td name="td1">5'-GGGAGAUACCAGCUUAUUCAAUUGCUUGGUACCGAGCUCGGAUCCACGUAGUAACGGGCCGCCAGUGUCUGGAAUUCGGGUCGUUCUUGAGAUAGUAAGUGCAAUCU-3'</td>
        <td name="td2">HIV-1 Rev protein</td>
        <td name="td3">19-36 nM</td>
      </tr>
	  </tbody>
     <tbody>
      <tr>
        <td name="td0">C17</td>
        <td name="td1">5'-GGGAGAUACCAGCUUAUUCAAUUGUAUUCUCCGUGGUUUAAUCAGAGUAGAGGAGCUGACUCCUUUGGUUGGACUACGUGGAGGUGCUCUUAGAUAGUAAGUGCAAUCU-3'</td>
        <td name="td2">HIV-1 Rev protein</td>
        <td name="td3">19-36 nM</td>
      </tr>
	  </tbody>
      <tbody>
      <tr>
        <td name="td0">C8</td>
        <td name="td1">5'-GGGAGAUACCAGCUUAUUCAAUUGAGCCAGUAAGUGACCCGUACUAAUACUGUUGAGUAGUAUGUAGAGGAGUGGUGAUCCUCCAAACUGCUGAGAUAGUAAGUGCAAUCU-3'</td>
        <td name="td2">HIV-1 Rev protein</td>
        <td name="td3">19-36 nM</td>
      </tr>
	  </tbody>
  </table>
<div style="display: flex; justify-content: center;"></div>
<img src="/images/SELEX_ligand/C52_aptamer_SELEX_ligand.svg" alt="drawing" style="width:800px;display:block;margin:0 auto;border-radius:0;" class="img-responsive">
<div style="display: flex; justify-content: center;"></div>
<br>
<br>



<p class="blowheader_box">Similar compound</p>                    
<font><p>We used the RCSB PDB website's similar structure search to find the top 10 structures similar to HIV-1 Rev protein (residues 34-50), and calculated TM-socre values and RMSD values using the TM-align website.</p></font>
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;">
      <thead>
      <tr>
        <th onclick="sortTable(0)">PDB</th>
        <th onclick="sortTable(1)">TM-socre</th>
        <th onclick="sortTable(2)">RMSD</th>
        <th onclick="sortTable(3)">Description</th>
      </tr>
      </thead>
    <tbody>
      <tr>
      <td name="td0">2LD2</td>
      <td name="td1">0.358</td>
      <td name="td2">0.89</td>
      <td name="td3">Solution structure of the N-terminal domain of huntingtin (htt17) in presence of DPC micelles</td>
    </tr>
     <tr>
      <td name="td0">1DNG</td>
      <td name="td1">0.442</td>
      <td name="td2">1.68</td>
      <td name="td3">NMR structure of a model hydrophilic amphipathic helical acidic peptide</td>
    </tr>
     <tr>
      <td name="td0">3N95-E</td>
      <td name="td1">0.034</td>
      <td name="td2">1.7</td>
      <td name="td3">Crystal structure of human CRFR2 alpha extracellular domain in complex with Urocortin 2</td>
    </tr>
     <tr>
      <td name="td0">1OMQ</td>
      <td name="td1">0.366</td>
      <td name="td2">1.1</td>
      <td name="td3">Structure of penetratin in bicellar solution</td>
    </tr>
     <tr>
      <td name="td0">7LSO</td>
      <td name="td1">0.44</td>
      <td name="td2">0.67</td>
      <td name="td3">L-Phenylseptin</td>
    </tr>
     <tr>
      <td name="td0">2RLG</td>
      <td name="td1">0.34</td>
      <td name="td2">0.79</td>
      <td name="td3">NMR structure of the antimicrobial peptide RP-1 bound to SDS micelles</td>
    </tr>
     <tr>
      <td name="td0">3N93-E</td>
      <td name="td1">0.03</td>
      <td name="td2">1.62</td>
      <td name="td3">Crystal structure of human CRFR2 alpha extracellular domain in complex with Urocortin 3</td>
    </tr>
     <tr>
      <td name="td0">7LSP</td>
      <td name="td1">0.465</td>
      <td name="td2">0.56</td>
      <td name="td3">D-Phenylseptin - The second residue of PHE of the peptide is a D-amino acid</td>
    </tr>
     <tr>
      <td name="td0">1O53</td>
      <td name="td1">0.371</td>
      <td name="td2">0.49</td>
      <td name="td3">Solution structure of the N-terminal membrane anchor of E. coli enzyme IIA(Glucose)</td>
    </tr>
     <tr>
      <td name="td0">6GS9</td>
      <td name="td1">0.303</td>
      <td name="td2">1.36</td>
      <td name="td3">NMR structure of aurein 2.5 in SDS micelles</td>
    </tr>
    </tbody>
  </table>
<p><br /></p>

                 
<p class="header_boxx6" id="references">References</p>
                
<a id="ref1"></a><font><strong>[1] RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo.</strong></font><br />
Symensma, T. L., Giver, L., Zapp, M., Takle, G. B., & Ellington, A. D.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/8523524/" target="_blank" style="color:#520049">Journal of virology, 70(1), 179–187. (1996)</a>
<br/>
            
<a id="ref2"></a><font><strong>[2] Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope.</strong></font><br />
Xu, W., & Ellington, A. D.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/8755498/" target="_blank" style="color:#520049">Proceedings of the National Academy of Sciences of the United States of America, 93(15), 7475–7480. (1996)</a>
<br/>
            
<a id="ref3"></a><font><strong>[3] Deep penetration of an alpha-helix into a widened RNA major groove in the HIV-1 rev peptide-RNA aptamer complex.</strong></font><br />
Ye, X., Gorin, A., Ellington, A. D., & Patel, D. J.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/8946856/" target="_blank" style="color:#520049">Nature structural biology, 3(12), 1026–1033. (1996)</a>
<br/>
            
<a id="ref4"></a><font><strong>[4] Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs.</strong></font><br />
Konopka, K., Düzgüneş, N., Rossi, J., & Lee, N. S.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/9713975/" target="_blank" style="color:#520049">Journal of drug targeting, 5(4), 247–259. (1998)</a>
<br/>
            
<a id="ref5"></a><font><strong>[5] Retention of conformational flexibility in HIV-1 Rev-RNA complexes.</strong></font><br />
Wilkinson, T. A., Zhu, L., Hu, W., & Chen, Y.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/15610009/" target="_blank" style="color:#520049">Biochemistry, 43(51), 16153–16160. (2004)</a>
<br/>
            
<a id="ref6"></a><font><strong>[6] Structure of an RNA Aptamer that Can Inhibit HIV-1 by Blocking Rev-Cognate RNA (RRE) Binding and Rev-Rev Association.</strong></font><br />
Dearborn, A. D., Eren, E., Watts, N. R., Palmer, I. W., Kaufman, J. D., Steven, A. C., & Wingfield, P. T.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/30017564/" target="_blank" style="color:#520049">Structure (London, England : 1993), 26(9), 1187–1195.e4. (2018)</a>
<br/>      